These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10731287)

  • 1. The impact of stent design and delivery upon the long-term efficacy of radioisotope stents.
    Fischell TA; Hehrlein C; Fischell RE; Fischell DR
    J Invasive Cardiol; 2000 Mar; 12(3):162-7. PubMed ID: 10731287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European high-activity (32)P radioactive stent experience.
    Albiero R; Colombo A
    J Invasive Cardiol; 2000 Aug; 12(8):416-21. PubMed ID: 10953106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages and limitations of radioactive stents.
    Hehrlein C; Kübler W
    Semin Interv Cardiol; 1997 Jun; 2(2):109-13. PubMed ID: 9546990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pathology: radiation-induced coronary artery disease in man and animals.
    Virmani R; Farb A; Carter AJ; Jones RM
    Semin Interv Cardiol; 1998; 3(3-4):163-72. PubMed ID: 10406688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioactive stents.
    Fischell TA
    Semin Interv Cardiol; 1998 Jun; 3(2):51-6. PubMed ID: 10212495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular brachytherapy in coronary arteries: the Rotterdam experience.
    Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ; De Pan C; Sipkema D; Marijnissen JP; Sabaté M; den Boer A; Serruys PW; Levendag PC
    Cardiovasc Radiat Med; 2000; 2(1):42-50. PubMed ID: 11229062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.
    Sheppard R; Eisenberg MJ; Donath D; Meerkin D
    Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose and dose rate effects of beta-particle emitting radioactive stents in a porcine model of restenosis.
    Carter AJ; Jenkins S; Sweet W; Bailey L; Jones R; Fischell TA; Virmani R
    Cardiovasc Radiat Med; 1999; 1(4):327-35. PubMed ID: 10828562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental results with endovascular irradiation via a radioactive stent.
    Carter AJ; Laird JR
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):797-803. PubMed ID: 8960505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on radiation for restenosis.
    French MH; Faxon DP
    Rev Cardiovasc Med; 2002; 3(1):1-6. PubMed ID: 12439348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to radiation therapy in animal restenosis models.
    Waksman R
    Semin Interv Cardiol; 1997 Jun; 2(2):95-101. PubMed ID: 9546998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure beta-particle-emitting stents inhibit neointima formation in rabbits.
    Hehrlein C; Stintz M; Kinscherf R; Schlösser K; Huttel E; Friedrich L; Fehsenfeld P; Kübler W
    Circulation; 1996 Feb; 93(4):641-5. PubMed ID: 8640989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience.
    Parenti DZ; Marsico F; Tosi G; Catalano G; Maiello L; Milone F; Carcagnì A; Pron PG; Orecchia R; Presbitero P
    Ital Heart J; 2003 Mar; 4(3):199-204. PubMed ID: 12784747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of stent on radiation dosimetry in an in-stent restenosis model.
    Fan P; Chiu-Tsao ST; Patel NS; Shih A; Ravi K; Sherman W; Tsao HS; Pisch J; Harrison LB
    Cardiovasc Radiat Med; 2000; 2(1):18-25. PubMed ID: 11229057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of beta irradiation in human coronary arteries.
    Urban P; Verin V; Popowski Y; Rutishauser W
    Semin Interv Cardiol; 1997 Jun; 2(2):125-31. PubMed ID: 9546993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-energy gamma-emitting stents inhibit intimal hyperplasia with minimal "edge effects" in a pig coronary artery model.
    Kutryk MJ; Kuliszewski MA; Jaffe R; Tio FO; Janicki C; Sweet WL; Sparkes JD; Strauss BH
    Cardiovasc Revasc Med; 2007; 8(1):28-37. PubMed ID: 17293266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving patient-specific dosimetry for intravascular brachytherapy.
    Li XA; O'Neill M; Suntharalingam M
    Brachytherapy; 2005; 4(4):291-7. PubMed ID: 16344260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of radioactive stents for the prevention of in-stent restenosis.
    Carter AJ; Fischell TA
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):127-33. PubMed ID: 9588927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.